Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
29.79
-0.24 (-0.80%)
At close: Oct 26, 2026, 4:00 PM EDT
29.74
-0.05 (-0.17%)
After-hours: Oct 26, 2026, 7:59 PM EDT

Pfizer Revenue

Pfizer had revenue of $15.03B in the quarter ending June 28, 2026, with 2.60% growth. This brings the company's total for the last twelve months to $63.70B, down -0.21% year-over-year. In the year 2025, Pfizer had annual revenue of $62.58B, down -1.65%. That makes Pfizer the 191st largest company in the world by revenue and 78th in the United States.

Revenue (ttm)
$63.70B
Revenue Growth
-0.21%
P/S Ratio
2.67
Revenue / Employee
$849,280
Employees
75,000
Market Cap
169.79B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Primary Care 26.82B 42.9%
  • Specialty Care 17.55B 28.1%
  • Oncology 16.83B 26.9%
  • Business Innovation (Pfizer CentreOne) 1.34B 2.1%

By Geography

Chart
  • United States 37.08B 59.2%
  • Developed Markets 16.19B 25.9%
  • Emerging Markets 9.31B 14.9%
Fiscal year ended Dec 31, 2025 See the full Pfizer breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202562.58B-1.05B-1.65%
Dec 31, 202463.63B4.07B6.84%
Dec 31, 202359.55B-41.62B-41.14%
Dec 31, 2022101.18B19.89B24.46%
Dec 31, 202181.29B39.64B95.16%
Dec 31, 202041.65B746.00M1.82%
Dec 31, 201940.91B80.00M0.20%
Dec 31, 201840.83B-11.72B-22.31%
Dec 31, 201752.55B-278.00M-0.53%
Dec 31, 201652.82B3.97B8.13%
Dec 31, 201548.85B-754.00M-1.52%
Dec 31, 201449.61B-1.98B-3.84%
Dec 31, 201351.58B-3.07B-5.62%
Dec 31, 201254.66B-6.38B-10.45%
Dec 31, 201161.04B-4.13B-6.34%
Dec 31, 201065.17B15.90B32.26%
Dec 31, 200949.27B973.00M2.01%
Dec 31, 200848.30B-122.00M-0.25%
Dec 31, 200748.42B47.00M0.10%
Dec 31, 200648.37B966.00M2.04%
Dec 31, 200547.41B--